Skip to main content

Lisinopril

NDC 62135-641 · Chartwell RX, LLC

Generic nameLisinopril
Dosage formTABLET
RouteORAL
Active ingredient(s)LISINOPRIL
Strength5 mg/1
Pharmacologic classAngiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA]
Marketing categoryANDA

Packages

62135-641-31 — 300 TABLET in 1 BOTTLE (62135-641-31)

62135-641-90 — 90 TABLET in 1 BOTTLE (62135-641-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

60687-667 — Lisinopril, 60687-678 — Lisinopril, 60760-063 — LISINOPRIL AND HYDROCHLOROTHIAZIDE, 60760-357 — Lisinopril, 60760-358 — Lisinopril, 60760-359 — Lisinopril, 60760-360 — Lisinopril, 60760-519 — Lisinopril and Hydrochlorothiazide Tablets, 60760-586 — Lisinopril and Hydrochlorothiazide Tablets, 62135-640 — Lisinopril, 62135-642 — Lisinopril, 62135-643 — Lisinopril, 62135-644 — Lisinopril, 62135-645 — Lisinopril, 63187-050 — Lisinopril and hydrochlorothiazide, 63187-051 — Lisinopril and hydrochlorothiazide, 63187-098 — Lisinopril, 63187-237 — Lisinopril, 63187-257 — Lisinopril, 63187-319 — LISINOPRIL AND HYDROCHLOROTHIAZIDE, +342 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels